The Need for Demonstrated Clinical Translational Evidence in Submissions to the IEEE Journal of Translational Engineering in Health and Medicine
Related Experiment Video
Updated: Jun 23, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Gerard Boyle1, Arturo Forner-Cordero2, Anubha Kalra3
1Department of Medical Physics and BioengineeringSt. James's Hospital Dublin D08 NHY1 Ireland.
Abstract:
The IEEE Journal of Translational Engineering in Health and Medicine (JTEHM) exists at the intersection of biomedical engineering and clinical practice. Published articles go beyond laboratory proof-of-concept to provide tangible, real-world evidence of translation into clinical settings. This editorial provides the rationale for manuscripts submitted to IEEE JTEHM to demonstrate evidence of clinical translation. It also provides examples of acceptable forms of evidence and offers guidance to authors on how to meet this expectation. Clinical and Impact-By requiring demonstrated clinical translational evidence IEEE JTEHM endeavours to publish high-quality research with scientific novelty and practical clinical impact. This expectation strengthens the journal's aim to accelerate the adoption of innovative solutions into healthcare systems and ultimately deliver quantifiable benefits to patients.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Current Trends in Nursing II
Clinical Trials: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Improving Translational Accuracy
Microorganisms in Medicine and Therapeutics
